InsiderTrades.com logo
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

AAEV Insider Trading

Insider Ownership Percentage: 0.95%
Insider Buying (Last 12 Months): £15,034.95
Insider Selling (Last 12 Months): GBX 0

Albion Enterprise VCT Insider Trading History Chart

This chart shows the insider buying and selling history at Albion Enterprise VCT by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Albion Enterprise VCT Share Price & Price History

Current Price: GBX 119.50
Price Change: +0.30 (1.20%)
As of 04/18/2024 02:53 AM ET

This chart shows the closing price history over time for AAEV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Secret Bull Market Starts in This Unusual Sector
From Altimetry   |   Ad
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Click for my No. 1 investment, all free of charge, click here. 

Albion Enterprise VCT Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2024Pippa LathamInsiderBuy11,655GBX 129£15,034.95
12/2/2022Christopher BurrowsInsiderBuy15,503GBX 129£19,998.87
See Full Table
Secret Bull Market Starts in This Unusual Sector
From Altimetry   |   Ad
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Click for my No. 1 investment, all free of charge, click here. 

SEC Filings (Institutional Ownership Changes) for Albion Enterprise VCT (LON:AAEV)

Albion Enterprise VCT PLC is a venture capital trust specializing in early and growth stage investments. It seeks to invest in the information technology, software, pharmaceutical services, leisure sector, healthcare technology and fintech sector related companies. It does not invest in companies that deal in property or shares and securities, banking and agriculture. The fund invests in smaller unquoted companies based in the United Kingdom and invests in shares or securities including loans with a five year or greater maturity period. It seeks to invest through a mixture of equity and secured loans. The gross assets of a portfolio company must not exceed £15 million ($17.39 million) immediately prior to the investment and £16 million ($18.55 million) immediately thereafter. The portfolio companies may receive more than £5 million ($5.80 million) in aggregate from all state aided providers of risk capital, including VCTs, in the 12-month period up to and including the most recent such investment.
Read More on Albion Enterprise VCT

Today's Range

Now: GBX 119.50
Low: 119.50
High: 119.50

50 Day Range

MA: GBX 116.93
Low: 113
High: 121

52 Week Range

Now: GBX 119.50
Low: 113
High: 124

Volume

N/A

Average Volume

25,018 shs

Market Capitalization

£120.07 million

P/E Ratio

5,975.00

Dividend Yield

5.26%

Beta

0.03

Who are the company insiders with the largest holdings of Albion Enterprise VCT?

Albion Enterprise VCT's top insider investors include:
  1. Christopher Burrows (Insider)
  2. Pippa Latham (Insider)
Learn More about top insider investors at Albion Enterprise VCT.
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>